| |
Report |
Presentation |
Webcast |
|
August 24, 2023
Presentation - EPB Bolagsdag
|
|
|
|
|
August 24, 2023
Interim Report Q2 2023
|
|
|
|
|
May 25, 2023
Presentation Erik Penser Bank
|
|
|
|
|
May 25, 2023
Interim Report Q1 2023
|
|
|
|
|
April 25, 2023
Annual Report 2022
|
|
|
|
|
February 23, 2023
Year-end Report 2022
|
|
|
|
|
November 17, 2022
Interim Report January – September 2022
|
|
|
|
|
August 25, 2022
Interim Report January – June 2022
|
|
|
|
|
May 25, 2022
Interim Report January – March 2022
|
|
|
|
|
May 5, 2022
Anglonordic Life Science Conference
|
|
|
|
|
April 28, 2022
Annual Report 2021
|
|
|
|
|
March 14, 2022
Oasmia Pharmaceutical – Aktiedagen Stockholm
|
|
|
|
|
January 19, 2022
Year-end Report 2021
|
|
|
|
|
January 19, 2022
Rights Issue Presentation at Erik Penser Bank
|
|
|
|
|
December 2, 2021
Oasmia - Presentation Erik Penser Bank
|
|
|
|
|
December 2, 2021
Presentation at Stora Aktiedagen Stockholm
|
|
|
|
|
November 18, 2021
Interim Report January – September 2021
|
|
|
|
|
October 21, 2021
Interview Erik Penser Bank
|
|
|
|
|
September 29, 2021
Naventus LifeScience Summit
|
|
|
|
|
September 7, 2021
Presentation at Aktiedagen Stockholm
|
|
|
|
|
August 19, 2021
Interim Report January – June 2021
|
|
|
|
|
June 11, 2021
Aktiespararna: Interview with Oasmia Pharmaceutical
|
|
|
|
|
May 27, 2021
Interim Report January – March 2021
|
|
|
|
|
April 29, 2021
Annual Report 2020
|
|
|
|
|
April 12, 2021
Cantrixil abstract from Final Phase I Data at the 2021 AACR Annual Meeting
|
|
|
|
|
March 21, 2021
BioEurope Spring, Virtual
|
|
|
|
|
March 11, 2021
Sachs 14th Annual European Life Sciences CEO Forum, Virtual
|
|
|
|
|
March 1, 2021
Oasmia acquires global development and commercialization rights for Cantrixil
|
|
|
|
|
February 19, 2021
Year-end report 2020
|
|
|
|
|
February 10, 2021
Swiss Nordic Bio
|
|
|
|
|
January 19, 2021
SEB Digital Healthcare Seminar Presentation
|
|
|
|
|
December 9, 2020
Interim Report May – October 2020 – Report
|
|
|
|
|
December 3, 2020
Oasmia’s Partner Elevar Provides an Update on Apealea Development Plans in Ovarian Cancer
|
|
|
|
|
November 11, 2020
Investival Showcase 11-16 November 2020, Virtual Conference
|
|
|
|
|
29 October, 2020
BIO-Europe®, Virtual Conference
|
|
|
|
|
October 7, 2020
Oasmia Erik Penser Cancer Day Presentation
|
|
|
|
|
September 24, 2020
Oasmia Erik Penser Investor Event Presentation
|
|
|
|
|
September 21, 2020
Presentation at Sachs Biotech in Europe Forum
|
|
|
|
|
September 15, 2020
Aktiedagen Digitalt
|
|
|
|
|
September 9, 2020
Interim Report May – July 2020
|
|
|
|
|
August 19, 2020
Annual Report 2019 / 2020
|
|
|
|
|
July 30, 2020
Analysguiden: Interview with Oasmia
|
|
|
|
|
June 18, 2020
Year-end Report 2019 / 2020
|
|
|
|
|
June 10, 2020
Company Presentation Aktiespararna
|
|
|
|
|
June 3, 2020
Avanza Börsdag
|
|
|
|
|
May 13, 2020
Strategic Review Presentation
|
|
|
|
|
March 27, 2020
Interim Report May 2019 – January 2020
|
|
|
|
|
March 25, 2020
Elevar deal
|
|
|
|
|
February 14, 2020
Oasmia appoints new CEO
|
|
|
|
|
December 30, 2019
Interim Report May – October 2019
|
|
|
|
|
September 26, 2019
Interim Report May – July 2019
|
|
|
|
|
September 5, 2019
Annual Report 2018 / 2019
|
|
|
|
|
June 28, 2019
Year-end Report 2018 / 2019
|
|
|
|
|
March 1, 2019
Interim report May 2018 – January 2019
|
|
|
|
|
November 20, 2018
Interim report May – October 2018
|
|
|
|
|
August 31, 2018
Interim report May – July 2018
|
|
|
|
|
August 24, 2018
Annual Report 2017 / 2018
|
|
|
|
|
June 7, 2018
Year-end Report May 2017 – April 2018
|
|
|
|
|
March 2, 2018
Interim report May 2017 – January 2018
|
|
|
|
|
December 1, 2017
Interim report May – October 2017
|
|
|
|
|
October 31, 2017
US Interim report May – October 2016
|
|
|
|
|
September 1, 2017
Interim Report May – July 2017
|
|
|
|
|
August 24, 2017
Annual Report 2016 / 2017
|
|
|
|
|
August 2, 2017
Registration statement on form F3
|
|
|
|
|
June 8, 2017
Year-end Report May 2016 – April 2017
|
|
|
|
|
April 30, 2017
20-F Annual Report 2016-05-01 – 2017-04-30
|
|
|
|
|
March 2, 2017
Interim Report May 2016 – January 2017
|
|
|
|
|
December 1, 2016
US Interim report May – October 2016
|
|
|
|
|
December 1, 2016
Interim Report May – October 2016
|
|
|
|
|
September 1, 2016
Interim Report May 2016 – July 2016
|
|
|
|
|
August 25, 2016
Annual Report 2015 / 2016
|
|
|
|
|
July 29, 2016
Updated Registration Statement on Form F1
|
|
|
|
|
July 8, 2016
Updated Registration Statement on Form F1
|
|
|
|
|
July, 2016
US Interim Report May 2016 – July 2016
|
|
|
|
|
July 1, 2016
Registration statement and Prospectus on Form F1
|
|
|
|
|
June 2, 2016
Year-end Report May 2015 – April 2016
|
|
|
|
|
April 30, 2016
20-F Annual Report 2015-05-01 – 2016-04-30
|
|
|
|
|
April, 2016
US Year-end Report May 2015 – April 2016
|
|
|
|
|
March 2, 2016
Interim Report May 2015 – January 2016
|
|
|
|
|
January, 2016
US Interim Report May 2015 – January 2016
|
|
|
|
|
December 2, 2015
Interim Report May – October 2015
|
|
|
|
|
December 2, 2015
US Interim Report May – October 2015
|
|
|
|
|
October, 2015
US Interim Report May – October 2015
|
|
|
|
|
September 2, 2015
Interim Report May – July 2015
|
|
|
|
|
August 20, 2015
Annual Report 2014 / 2015
|
|
|
|
|
July 7, 2015
Updated Registration Statement and Prospectus on Form F1
|
|
|
|
|
June 3, 2015
Year-end Report May 2014 – April 2015
|
|
|
|
|
March 4, 2015
Interim Report May 2014 – January 2015
|
|
|
|
|
December 3, 2014
Interim Report May – October 2014
|
|
|
|
|
November, 2014
Prospectus new share issue November 2014
|
|
|
|
|
September 4, 2014
Interim Report May-July 2014
|
|
|
|
|
August 21, 2014
Annual Report 2013 / 2014
|
|
|
|
|
June 5, 2014
Year-end Report May 2013 – April 2014
|
|
|
|
|
March 6, 2014
Interim Report May 2013 – January 2014
|
|
|
|
|
December 5, 2013
Interim Report May – October 2013
|
|
|
|
|
September 6, 2013
Interim Report May – July 2013
|
|
|
|
|
August, 22 2013
Annual Report 2012 / 2013
|
|
|
|
|
June 7, 2013
Year-end Report May 2012 – April 2013
|
|
|
|
|
March 1, 2013
Interim Report May 2012 – January 2013
|
|
|
|
|
December 6, 2012
Interim Report May-October 2012
|
|
|
|
|
October 25, 2012
New share issue Prospectus 2012-10-25
|
|
|
|
|
September 6, 2012
Interim Report May-July 2012
|
|
|
|
|
August 23, 2012
Annual Report 2011 / 2012
|
|
|
|
|
June 14, 2012
Year-end Report May 2011-April 2012
|
|
|
|
|
March 8, 2012
Interim Report May 2011 – January 2012
|
|
|
|
|
December 8, 2011
Interim Report May – October 2011
|
|
|
|
|
November 1, 2011
New share issue Prospectus 2010-11-01
|
|
|
|
|
September 8, 2011
Interim Report May – July 2011
|
|
|
|
|
August 25, 2011
Annual Report 2010 / 2011
|
|
|
|
|
June 10, 2011
Year-end Report May 2010 – April 2011
|
|
|
|
|
March 9, 2011
Interim Report May 2010 – January 2011
|
|
|
|
|
December 9, 2010
Interim Report May-October 2010
|
|
|
|
|
September 9, 2010
Interim Report May – July 2010
|
|
|
|
|
August 26, 2010
Annual Report 2009 / 2010
|
|
|
|
|
June 10, 2010
Year-end Report May 2009 – April 2010
|
|
|
|
|
June 6, 2010
Listing Prospectus OMX 2010-06-17
|
|
|
|
|
February 26, 2010
Interim Report May 2009 – January 2010
|
|
|
|
|
December 10, 2009
Interim Report May 2009-October 2009
|
|
|
|
|
September 17, 2009
Oasmia Listing Prospectus 2007-09-17
|
|
|
|
|
September 10, 2009
Interim report May 2009 – July 2009
|
|
|
|
|
August 28, 2009
Annual Report 2008 / 2009
|
|
|
|
|
March 19, 2009
Interim report May 2008 – January 2009
|
|
|
|
|
December 10, 2008
Interim Report May 2008 – October 2008
|
|
|
|
|
September 16, 2008
Interim Report May – July 2008
|
|
|
|
|
August 29, 2008
Annual Report 2007 / 2008
|
|
|
|
|
June 16, 2008
Year-end Report 2007-05-01 – 2008-04-30
|
|
|
|
|
March 14, 2008
Interim Report May 2007 – January 2008
|
|
|
|
|
December 14, 2007
Interim Report May – October 2007
|
|
|
|
|
September 10, 2007
Communiqué from Annual General Meeting 2007-09-10
|
|
|
|
|
June 15, 2007
Year-end Report 2006-05-01 – 2007-04-30
|
|
|
|
|
December 10, 2006
Interim Report May – October 2006
|
|
|
|
|
August 14, 2006
Annual Report 2005 / 2006
|
|
|
|
|
September 27, 2005
Annual Report 2004 / 2005
|
|
|
|
